The Antibody Discovery and Development Seminar, hosted by Johns Hopkins Technology Ventures and Bluefield Innovations, will review Bluefield Innovation’s Fall 2019 funding cycle, through which investigators can secure multi-million dollar project funding, which to-date have provided JHU faculty with more than $30M in funding commitments so far. The event on September 24 will consist of an expert-led(...)
Innovation
JHU Grand Challenge: Next-generation Innovations for Consumer Health and Empowerment (NICHE)
Posted by | ResearchGSK Consumer Healthcare will invest $700,000 this year to seek applications from JHU faculty (including APL) based on novel science, technologies, materials or processes that will lead to improved consumer health outcomes and that align with GSK’s consumer strategic needs - to improve the quality of human life by enabling people to do more, feel(...)
Introducing Bluefield Innovations
Posted by | ResearchThe Johns Hopkins University and Deerfield Management have recently announced the creation of Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics. Funded by Deerfield, an investment management firm committed to advancing health care, Bluefield Innovations will provide up to $65 million in initial funding over five years to support the commercialization(...)
JHTV Seeking New Medical Director
Posted by | ResearchFollowing the tradition of the Bus Dev and Strategic Alliance Group Medical Directors, Johns Hopkins Technology Ventures is seeking a commercialization savvy JHM faculty member to spend a portion of their time helping our efforts. As Mike Weisfeldt prepares to retire in December from his work at JHTV, we are looking for 1 to 2 people to fill(...)
Speed Dating with the APL
Posted by | ResearchThe Johns Hopkins Applied Physics Lab (APL) is partnering with the Department of Surgery and the Department of Medicine for a “speed dating” event on Thursday, September 7 from 3–5 p.m. in the Welch Library. This interactive session will allow multiple short introductions between surgeons and engineers. This year's focus will be in the following areas: wearables(...)
Kass and Pasricha Receive Clinician Innovator Mentor Awards
Posted by | Congratulations, ResearchDavid Kass, professor in Cardiology, and Jay Pasricha, professor in Gastroenterology, were named recipients of the Johns Hopkins Clinician Innovator Mentor Award at the 2017 Design Day hosted by Center for Bioengineering Innovation and Design on Tuesday, May 9. This award recognizes clinicians who have made significant progress in developing new health care solutions that(...)
Call for Sanofi Innovation Award Pre-Proposals
Posted by | ResearchJohns Hopkins School of Medicine and nine other major peer institutions (The University of Pennsylvania, Cornell University, Columbia University, Brigham and Women’s Hospital, Massachusetts General Hospital, the University of Texas System, The Children’s Hospital of Philadelphia, Boston Children’s Hospital and The Regents of the University of California, on behalf of its San Francisco campus) have entered(...)
Entrepreneurial Mentorship Program
Posted by | LeadershipPlease join us on May 10 for the Hopkins Biotech Network’s Entrepreneurial Mentorship Program Showcase! Event highlights include a panel discussion with entrepreneurial mentors and industry leaders, success stories from current participants in the program and opportunities to connect with fellow entrepreneurs. Hear from peers who have successfully mapped their journey in entrepreneurship and discover new(...)
Developing a Treatment for Two Leading Causes of Blindness: dry-AMD and Stargardt Disease-Lessons from a Life Sciences Startup
Posted by | CMEWhen: Wednesday, March 8 from 4:30-5:30 p.m. (with reception to follow) Where: Sheikh Zayed Tower, Room 2119A, Chevy Chase Conference Ctr Featured Speaker: Dr. Josh Boger, Executive Chairman , Alkeus Pharmaceuticals, Inc. Founder, Director and CEO (Former) of Vertex Pharmaceuticals Incorporated About the Speaker: Dr. Joshua Boger is the founder of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and(...)